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DOI 10.1186/s12884-015-0486-3RESEARCH ARTICLE Open AccessIncreasing uptake of influenza vaccine by
pregnant women post H1N1 pandemic: a
longitudinal study in Melbourne, Australia,
2010 to 2014
Elizabeth Anne McCarthy1*, Wendy Elizabeth Pollock2, Lauren Tapper3, Maree Sommerville4 and Susan McDonald2Abstract
Background: A Melbourne (Australia) university affiliated, tertiary obstetric hospital provides lay and professional
education about influenza vaccine in pregnancy annually each March, early in the local influenza season.
Responding to a 2011 survey of new mothers' opinions, the hospital made influenza vaccine freely available in
antenatal clinics from 2012. We wished to determine influenza vaccination uptake during pregnancy with these
strategies 5 years after 2009 H1N1.
Methods: Face to face interviews based on US Center for Disease Control and Prevention Pregnancy Risk
Assessment Monitoring System with new mothers in postnatal wards each July, 2010 to 2014. We calculated
recalled influenza vaccine uptake each year and assessed trends with chi square tests, and logistic regression.
Results: We recorded 1086 interviews. Influenza vaccination during pregnancy increased by 6% per year (95%
confidence interval 4 to 8%): from 29.6% in 2010 to 51.3% in 2014 (p < 0.001). Lack of discussion from maternity
caregivers was a persistent reason for non-vaccination, recalled by 1 in 2 non-vaccinated women. Survey respondents
preferred face to face consultations with doctors and midwives, internet and text messaging as information sources
about influenza vaccination. Survey responses indicate messages about vaccine safety in pregnancy and infant benefits
are increasingly being heeded. However, there was progressively lower awareness of maternal benefits of influenza
vaccination, especially for women with risk factors for severe disease.
Conclusions: We observed improving influenza vaccination during pregnancy. There is potential to integrate
technology such as text message or internet with antenatal consultations to increase vaccination coverage further.
Keywords: Pregnancy complications, Infectious/prevention & control, Influenza vaccines/immunology, TrivalentBackground
Influenza illness threatens lives of pregnant women, new
mothers [1] and babies [2]. Influenza vaccination pre-
vents maternal and infant febrile respiratory illness [3]
and reduces preterm birth and fetal growth restriction
[4]. The World Health Organization prioritises pregnant
women for influenza vaccination [5]. Influenza vaccine
uptake has been suboptimal in pregnant women [6].
Women and/or maternity caregivers may underestimate* Correspondence: eamcca@unimelb.edu.au
1Department of Obstetrics and Gynaecology, University of Melbourne, Level 3,
Mercy Hospital for Women, 163 Studley Road, Heidelberg, Victoria 3084, Australia
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unless otherwise stated.illness severity, overestimate vaccine side effects and face
logistic obstacles to vaccination during pregnancy [6].
We, like others, promote influenza vaccination during
pregnancy with hospital based professional and lay edu-
cation and deliver seasonal vaccines to consenting staff,
inpatients and outpatients at no cost to the person being
vaccinated [6]. In the five years since the 2009 H1N1
pandemic wrought serious consequences for pregnant
women and their infants, maternity care providers’
awareness of influenza illness and vaccine has increased,
but the level of awareness before 2009 may have been
close to zero [7]. Having observed an increase in vaccine
uptake among pregnant women soon after the 2009ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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trends in vaccine uptake with current vaccine promotion
procedures. Our objective was to review enabling and
obstructing factors in promoting influenza vaccination
during pregnancy to inform future lay and professional
educational efforts.
Methods
Setting
The setting was a university affiliated women’s hospital
in Melbourne (38° S latitude) with neonatal intensive
care facilities and approximately 6,000 births per year,
located adjacent to a 400 bed general hospital with a 29
bed adult intensive care unit. The hospital serves local
women as well as being one of three hospitals with neo-
natal intensive care serving about 70,000 births per
annum in the state of Victoria, Australia.
Vaccine policies, procedures and promotion
National public health policies promoted influenza vac-
cination at all stages of pregnancy during the survey
period, reinforced by a November 2011 Royal Australian
and New Zealand College of Obstetricians and Gynae-
cologists (RANZCOG) statement [9]. General practi-
tioners, workplaces and local health authorities are the
main providers of seasonal influenza vaccination in
Victoria. The study hospital increased professional edu-
cation, patient information brochures in antenatal clinics
and ward areas after the 2010 survey [8] with more read-
ily accessible vaccine supplies for patients from 2012.
Survey method and instrument
Mercy Health Human Research Ethics Committee ap-
proved this audit project and all participants gave verbal
consent to anonymous data collection. As previously de-
scribed [8], we administered a structured interview based
on the US Center for Disease Control and Prevention
Pregnancy Risk Assessment Monitoring System (PRAMS)
Phase 6 (2009) Topic Reference Questionnaire [10] to
postnatal inpatient women. Eligible women had given
birth to live infants on any day of 2 consecutive weeks
each July.
Academic midwifery and obstetric staff interviewed
participants 2010 to 2012 and funded research assistants
administered survey interviews in 2013 and 2014. We
collected non-identifiable data about maternal age,
country of birth, gestational age at childbirth, and model
of antenatal care as well as whether or not participant
women chose influenza vaccination, their reasons for
their choice and whether they recall vaccination during
pregnancy. From 2012, we also asked for women’s views
about text messaging and other information sources
about influenza vaccination. A copy of the questionnaire
is available as a Additional file 1.Statistical methods
Staff availability for quality assurance determined sample
size in 2010 and 2011. Observing an increase in influ-
enza vaccine coverage from 30 to 40% between 2010 and
2011 [8], we aimed to duplicate the audit duration each
year. Anticipating about 200 births in 14 consecutive
days, the sample size is powered to demonstrate an in-
crease in coverage from 30% by 6 % or more with 80%
power (1-beta) and 2-sided alpha of 5% [11]. Data were
entered and analysed in SPSS (v 21). We used chi-square
to test the hypothesis that proportions changed over
time and binary logistic regression to estimate the effect
of year of audit on recalled vaccine uptake. Because mul-
tiple secondary trends were sought concerning women’s
reasons for or against vaccination, we focused, conserva-
tively on very low p values (less than 0.01).
Results
Data were available for 1086 women who participated in
the study over five years. Response rates were high: more
than 91% of women completed surveys in four of five
audit years (2010 (199/212 = 93.9%), 2011 (240/251 =
95.6%), 2013 (253/260 = 97.3%) and 2014 (191/208 =
91.8%). A clerical oversight left only 203 records of 259
postnatal women (79.9%) in 2012 available for analysis.
Reasons for non-participation were collected for 2010,
2011 and 2014 (41 of 671 women). Five women (0.8%)
suffered perinatal death and were not invited to partici-
pate, 23 (3.4%) were discharged home before the inter-
view could be completed, 7 (1.0%) lacked an appropriate
interpreter and 6 (0.9%) declined participation.
Demographic and obstetric characteristics of respon-
dents were similar to our previous report [8]. Sixty-two per
cent of women (676/1086) were Australian born, 9 women
(0.8%) identified as Indigenous and 18 (1.7%) completed
the survey with interpreter assistance. Thirteen teenaged
mothers participated (1.2%) and more than 1 in 4 partici-
pants (296 or 27.3%) were aged 35 or older. Most partici-
pants used publically funded, hospital-based antenatal care
(72.0%). Other women attended general practitioners for
shared antenatal care (17.1%), private obstetricians (10.5%)
or other services (0.4%). No trends were identified in ma-
ternal age structure or proportions of women who were
overseas-born, identified as indigenous or used private ob-
stetric care: see Additional file 2. The majority of births
(89%) were at gestation 37 to 41 completed weeks, 8.9%
were at 20 to 36 + 6 weeks, 0.8% of births at 42 or more
weeks and gestational age was missing information for 1%
of respondents.
Influenza vaccination uptake showed a statistically sig-
nificant upward gradient from 30% in 2010 to over 50%
in 2014 (chi-square for trend p < 0.01. See Table 1).
Overall, 461 of 1086 women (42.3%) recalled vaccination
during pregnancy. Binary logistic regression modelling
Table 1 Influenza vaccination coverage during pregnancy
as judged by recall of women soon after childbirth
Survey
year
Women recalling
influenza
vaccination
during
pregnancy (N)
Women stating
they were
not influenza
vaccinated
during
pregnancy (N)
Total
completing
survey (N)
Recalled
vaccine
uptake (%)
2010 59 140 199 29.6%
2011 95 145 240 39.6%
2012 72 131 203 35.5%
2013 137 116 253 54.2%
2014 98 93 191 51.3%
All
years
461 625 1086 42.2%
Pearson Chi-Square = 39.4, df = 4, p < 0.001.
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scribed by a constant and increasing rate according to
year of audit (Y) as follows: Log Odds (recalled vaccin-
ation) = −0.804 + 0.248(Y), Exp (Y) = 1.28 (95% confi-
dence interval (CI) 1.171 to 1.402) where Y represents
the number of years after 2010. The model gives a gradi-
ent of 6% increase in uptake per year (95% CI 4% to 8%).
Four hundred and thirteen of 635 women (65.0%) who
recalled vaccination being discussed or recommended by a
health care worker were subsequently vaccinated compared
with 48 of 491 women (10.7%) who did not recall a discus-
sion or recommendation (Pearson chi-square p < 0.001).
Table 2 lists reasons given by women who chose to be
vaccinated against influenza during pregnancy. The top
ranking reason across the 5 year period was the desire to
protect the infant, increasing from 66.7% in 2010 to
89.2% of influenza vaccinated women in 2014 (Pearson
Chi-Square p = 0.001).
The wish to prevent maternal illness was less commonly
reported after 2010. Sixty-five per cent cited this reason in
2010; lower proportions (20% to 55%) reported this in sub-
sequent years (p < 0.001). Risk factors for severe maternal
influenza disease are common and include obesity, diabetes,
smoking and asthma, but were infrequently reported as rea-
sons for immunisation. The proportion of women reporting
having a chronic medical condition as a reason for influ-
enza vaccination during pregnancy fell from 11.7% in 2010
to less than 5% in subsequent years (p = 0.005).
Substantial proportions of women reported general
practitioner recommendation (44.5%), regular annual
immunisation (35.4%) or obstetrician recommendation
(28.0%) with no discernible trends over 5 years. Propor-
tions of influenza vaccinated women recalling midwifery
recommendations varied widely between audit years but
remained higher than the 2010 level (15.0%) in subse-
quent years (p < 0.001). More than 1 in 4 (25.8%) women
overall reported that a midwife recommendation hadbeen a reason for choosing influenza immunisation
during pregnancy.
Pregnant women increasingly sought influenza vac-
cine. Whereas 8.8% (32/368) of vaccinated women
recalled seeking vaccination in 2010 to 2013, the propor-
tion of vaccinated women who remember asking for
vaccination was much higher at 42% (41/98) in 2014.
Table 3 lists reasons cited by women for not being vac-
cinated during pregnancy. The two most common rea-
sons did not change with time. Around one-half (50.9%)
of non-vaccinated women did not recall influenza vac-
cination being mentioned by midwives or doctors and a
similar proportion (47.1%) reported choosing against
vaccination during pregnancy because they are not usu-
ally vaccinated when not pregnant.
Maternal concerns about vaccine side effects became
less common over time. The proportion of non-vaccinated
women expressing concerns about safety for the fetus or
infant almost halved from 60.9% in 2010 to 30.8% in 2014
(p < 0.001). The proportion of non-vaccinated women
reporting concerns about vaccine side effects for them-
selves declined from 46.4% in 2010 to 29.7% in 2014 (p <
0.001). Overall, 35 of 1086 women (3.2%) reported receiv-
ing advice against influenza vaccination during pregnancy
from a general practitioner, obstetrician or midwife (See
Additional file 3). In 2013 to 2014 only 2 women (0.5%)
reported this advice.
Regarding preferred sources of information about vac-
cination for 647 women interviewed in 2012 to 2014,
272 (42.0 %) of women nominated face to face discus-
sion with a doctor or midwife. Slightly more women 345
(53.3%) were positive about receiving a text message re-
minder about influenza vaccination. Internet sourced in-
formation was also popular (125 women or 19.3%), more
often mentioned than antenatal classes, brochures,
email, books or mass media.
Discussion
In the quest to protect pregnant women, their unborn
and newly born children from influenza and its compli-
cations, our survey gives some cause for optimism. Vac-
cine coverage has increased from around 30% to 51% in
the five years after 2009. Our findings are similar to
those from a study conducted in the United States of
America [12] as well as recent research from Western
Australia [13]. It is uncertain the extent to which the
processes of annual audit themselves promote vaccin-
ation, that is, a Hawthorne effect.
Infant or fetal benefits of influenza vaccination are in-
creasingly common reasons for pregnant women to seek
vaccination. Pregnant women’s decision-making for vac-
cination in favour of the fetus or newborn has been
noted in quantitative [6] and qualitative [14] studies. We
observed lower rates of concerns about vaccine side-
Table 2 Reasons women gave for electing FOR influenza immunisation in pregnancya
Respondents recalling
influenza vaccination
during pregnancy
I normal have
flu vaccine
To prevent maternal illness Chronic medical
conditions
Midwife
recommended
vaccination
GP recommended
vaccination
Obstetrician
recommended
vaccination
To protect the baby
Year N n n/N (%) n n/N (%) n n/N (%) n n/N (%) N n/N (%) N n/N (%) n n/N (%)
2010 60 23 38.3% 39 65.0% 7 11.7% 9 15.0% 39 65.0% 14 23.3% 40 66.7%
2011 94 27 28.7% 50 53.2% 11 11.7% 41 43.6% 39 41.9% 38 41.3% 61 65.6%
2012 72 33 45.8% 37 51.4% 3 4.2% 15 20.8% 33 45.8% 19 26.4% 52 72.2%
2013 139 42 30.2% 28 20.1% 2 1.4% 22 15.8% 58 41.7% 30 21.6% 92 66.2%
2014 93 37 39.8% 52 55.3% 4 4.4% 31 33.3% 34 37.0% 27 28.7% 83 89.2%
Chi-square, (df) 7.9, (4) 52.2, (4) 14.9, (4) 30.2, (4) 13. 1, (4) 11.7, (4) 18.7, (4)
p 0.095 <0.001* 0.005*b <0.001* 0.011 0.020 0.001*
Results are based on nonempty rows and columns in each innermost sub-table.
*The Chi-square statistic is significant at the 0.01 level.
aWomen could nominate more than one reason.
bMore than 20% of cells in this sub-table have expected cell counts less than 5. Chi-square results may be invalid.
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Table 3 Reasons women gave for electing AGAINST influenza immunisation in pregnancya
Number of women stating not
vaccinated during pregnancy
No one
mentioned flu
vaccination
GP advised
against
vaccination
Obstetrician
advised against
vaccination
Midwife advised
against vaccination
Concerned about
maternal vaccination
effects
Concerned
about baby
vaccination
effects
Not pregnant
during the
flu season
First trimester
so avoided
vaccine
Year N n n/N (%) n n/N (%) n n/N (%) n n/N (%) n n/N (%) n n/N (%) n n/N (%) n n/N (%)
2010 139 75 54.0% 6 4.3% 1 0.7% 2 1.4% 64 46.4% 84 60.9% 0 0.0% 0 0.0%
2011 146 65 44.5% 6 4.1% 2 1.4% 0 0.0% 57 39.0% 62 42.5% 4 2.8% 1 0.7%
2012 131 72 55.0% 8 6.1% 3 2.3% 5 3.8% 32 24.4% 34 26.0% 1 0.8% 0 0.0%
2013 114 60 52.6% 2 1.8% 0 0.0% 0 0.0% 21 18.4% 25 21.9% 2 1.8% 0 0.0%
2014 91 44 48.4% 0 0.0% 0 0.0% 0 0.0% 27 29.7% 28 30.8% 1 1.1% 0 0.0%
Chi-square, (df) 4.1, (4) 32.7, (3) 19.7, (3) 5.6, (3) 29.5, (4) 54.6, (4) 4.7, (4) 1.9, (2)
p 0.388 b b <0.001* <0.001* b b
*The Pearson Chi-square statistic is significant at the .01 level.
aWomen could nominate more than one reason.
bChi-square not calculated as > 20% of cells have expected cell counts < 5.
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compared with earlier surveys. Hospital consumer infor-
mation and professional education about influenza vac-
cination addresses infant benefits and vaccine safety for
mother and infant so our observations support the ef-
fectiveness of such education. We suggest that other
antenatal vaccination programmes, such as pertussis,
would be feasible with similar consumer information,
professional education and logistic support.
Progressively fewer women nominated protection from
severe maternal disease or recognised specific maternal
risk factors as reasons for vaccination in the 5 years after
the H1N1 pandemic. Close experience with a vaccine pre-
ventable disease is a recognised driver for immunisation
[14]. Possibly memories of severe influenza illness among
pregnant women during 2009 are fading. It is important
for health care professionals and lay people to realise that
pregnant women remain vulnerable to severe influenza
disease in non-pandemic as well as pandemic years.
Although increasing, influenza vaccine coverage
among childbearing women remains suboptimal. Health
care provider advice is often the most important deter-
minant of vaccine uptake [13]. Lack of discussion, rather
than active advice against vaccination remains a com-
mon, potentially reversible reason for non-vaccination
[12,13]. The observed rates of influenza vaccination up-
take when a health care worker had recommended or
discussed vaccination was 65%, very similar to compar-
able USA data of 70.5% [12]. This contrasts with 10.7%
vaccination coverage among current study participants
who did not recall a health care provider recommendation
or discussion: very similar to the rate of 9.7% recorded in
the comparable recent survey conducted in the USA [12].
Reports of HCW advising against influenza vaccination (in
just over 3% of current survey participants) were not vali-
dated externally. These reports appear to be reducing over
recent years. Participants, healthcare professionals or both
may have confused recommendations about when to vac-
cinate against influenza with postpartum recommenda-
tions to vaccinate against diseases such as rubella and
varicella zoster which require live vaccination. Participants
and/or health care professionals may also have confused
recommended antenatal influenza vaccination timing with
pertussis postnatal timing (cocooning strategies) which
were recommended at the time of survey.
Strengths of our study include good acceptability of the
survey to newly postpartum women and thus high uptake
which makes the findings generalizable to our tertiary hos-
pital setting. Survey participants were representative of
maternal and gestational age, and of cultural and linguistic
diversity served by this hospital. Missing data from the
2012 survey could introduce unknown biases, but the re-
sponse rate of close to 80%, compares favourably with
other publications: more than half of surveillance reportsof influenza vaccination during pregnancy published up to
2013 reported response rates of < 70% [6].
That newly postpartum women in the current study
are well disposed towards text message reminders about
vaccination during pregnancy encourages programmes
similar to those used in an urban USA research setting
which confirmed modest but positive increased uptake
of influenza vaccination among pregnant women when
serial text messages, linked to an electronic health rec-
ord, are sent during autumn and winter [15].
Our study has some weaknesses. We relied on patient
self-report of vaccination and the anonymised nature of
the survey prevented confirmation. Nevertheless, other
studies confirm accuracy of self-report [16,17]. Data are
limited to a single institution rather than multi-centre
[16,18]. Regardless, our findings support local vaccine pro-
motion strategies within a national vaccination programme.
Our study lacks information about education or income for
respondents. Anecdotally, some women now expect influ-
enza vaccination every pregnancy, particularly if they were
pregnant during the 2009 H1N1 pandemic, but we did not
have information about previous pregnancies so cannot
examine this impression quantitatively. The national
Woman Held Pregnancy Record [19] contains a field to
document influenza vaccination during pregnancy thus
supporting integration into routine pregnancy care.
Conclusions
We surveyed new mothers as inpatients between 2010
and 2014 and were heartened to find influenza vaccine
coverage during pregnancy is now more than 50%. There
is still scope to protect more individual women and in-
fants and increase herd immunity. Survey responses sug-
gest that messages about vaccine safety in pregnancy
and infant benefits are increasingly being heeded.
Survey responses indicate progressive lower awareness
of maternal benefits of influenza vaccination, especially for
women with risk factors for severe disease such as over-
weight and obesity, smoking, lung disease or diabetes.
Those working to increase lay and professional awareness
of the gravity and preventability of maternal influenza in-
fection need to engage with and listen to childbearing
women and other stakeholders, and be honest and open
about uncertainty and risks of disease or vaccination pro-
grammes may not succeed [20].
An important, potentially reversible obstacle to influenza
vaccination during pregnancy is lack of recommendation
from health care providers. Around 1 in 2 non-vaccinated
women state that lack of discussion with a maternity care
provider was a reason for non-vaccination, an obstacle also
identified in Australia and other countries [6,12,13]. There
is scope to use text message and internet to support face to
face discussion about influenza vaccination in pregnancy
between women and maternity caregivers.
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